ODTX logo
NASDAQ · ODTXBiotechnologyUpdated Oct 23, 2026

Odyssey Therapeutics, Inc. ROE

Profitability, historical returns, and peer comparisons.

The ROE as of October 2026 (TTM) for Odyssey Therapeutics, Inc. (ODTX) is 177.71%

According to Odyssey Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is 177.71%. This represents a change of -6900.86% compared to the average of -2.61% of the last 4 quarters.

Odyssey Therapeutics, Inc. (ODTX) Historical ROE (quarterly & annually)

How has ODTX ROE performed in the past?

The mean historical ROE of Odyssey Therapeutics, Inc. over the last ten years is 30.44%. The current 177.71% ROE has changed 483.73% with respect to the historical average. Over the past ten years (40 quarters), ODTX's ROE was at its highest in in the March 2026 quarter at 7.31%. The ROE was at its lowest in in the June 2026 quarter at -12.53%.

Quarterly (TTM)
Annual

Average

30.44%

Median

30.44%

Minimum

30.44%

Maximum

30.44%

Odyssey Therapeutics, Inc. (ODTX) ROE by Quarter and Year

Discovering the peaks and valleys of Odyssey Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 0%

Maximum Annual ROE = 30.44%

Minimum Annual Increase = 0%

Minimum Annual ROE = 30.44%

Quarterly (TTM)
Annual
YearROEChange

Odyssey Therapeutics, Inc. (ODTX) Average ROE

How has ODTX ROE performed in the past?

The current ROE of Odyssey Therapeutics, Inc. (ODTX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

30.44%

5-year avg

30.44%

10-year avg

30.44%

Odyssey Therapeutics, Inc. (ODTX) ROE vs. Peers

How is ODTX’s ROE compared to its peers?

Odyssey Therapeutics, Inc.’s ROE is less than AnaptysBio, Inc. (2.52%), greater than Immunic, Inc. (-157.89%), greater than Spyre Therapeutics, Inc. (-24.32%), greater than Aclaris Therapeutics, Inc. (-61.65%), greater than Alumis Inc. (-102.97%), greater than Oruka Therapeutics, Inc. (-20.76%), less than Protagonist Therapeutics, Inc. (12.03%), greater than AgomAb Therapeutics N.V. American Depositary Shares (-19.70%),

Build a custom stock screener for Odyssey Therapeutics, Inc. (ODTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Odyssey Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Odyssey Therapeutics, Inc. (ODTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Odyssey Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Odyssey Therapeutics, Inc.'s ROE?

How is the ROE calculated for Odyssey Therapeutics, Inc. (ODTX)?

What is the highest ROE for Odyssey Therapeutics, Inc. (ODTX)?

What is the 3-year average ROE for Odyssey Therapeutics, Inc. (ODTX)?

What is the 5-year average ROE for Odyssey Therapeutics, Inc. (ODTX)?

How does the current ROE for Odyssey Therapeutics, Inc. (ODTX) compare to its historical average?